Document is current
Any future updates will be listed below
-
Authors
Deckers, Kay
Zwan, Marissa D.
Soons, Lion M.
Waterink, Lisa
Beers, Sonja
van Houdt, Sofie
Stiensma, Berrit
Kwant, Judy Z.
Wimmers, Sophie C. P. M.
Heutz, Rachel A. M.
Claassen, Jurgen A. H. R.
Oosterman, Joukje M.
de Heus, Rianne A. A.
van de Rest, Ondine
Vermeiren, Yannick
Voshaar, Richard C. Oude
Smidt, Nynke
Broersen, Laus M.
Sikkes, Sietske A. M.
Aarts, Esther
,
,
Köhler, Sebastian
van der Flier, Wiesje M.
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611, 17611)
- License Information
-
More Information
Article History
Received: 2 May 2024
Accepted: 10 June 2024
First Online: 13 June 2024
Declarations
:
: The FINGER-NL trial has been reviewed and approved by the Medical Ethical Committee VU Medical Center (NL77242.029.21; Amsterdam, The Netherlands), is registered under ClinicalTrials.gov (ID: NCT05256199) and the Netherlands Trial Register (NL9634), and is conducted in line with the Declaration of Helsinki. Written informed consent for participation was obtained from all participants at the baseline study visit.
: Research programs of WF have been funded by ZonMW, NWO, EU-JPND, EU-IHI, Alzheimer Nederland, Hersenstichting CardioVascular Onderzoek Nederland, Health ~ Holland, Topsector Life Sciences & Health, stichting Dioraphte, Gieskes-Strijbis fonds, stichting Equilibrio, Edwin Bouw fonds, Pasman stichting, stichting Alzheimer & Neuropsychiatrie Foundation, Philips, Biogen MA Inc, Novartis-NL, Life-MI, AVID, Roche BV, Fujifilm, Eisai, Combinostics. WF holds the Pasman chair. WF is recipient of ABOARD, which is a public–private partnership receiving funding from ZonMW (#73305095007) and Health ~ Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). WF is recipient of TAP-dementia (), receiving funding from ZonMw (#10510032120003) in the context of Onderzoeksprogramma Dementie, part of the Dutch National Dementia Strategy. WF has been an invited speaker at Biogen MA Inc, Danone, Eisai, WebMD Neurology (Medscape), NovoNordisk, Springer Healthcare, European Brain Council. WF is consultant to Oxford Health Policy Forum CIC, Roche, Biogen MA Inc, and Eisai. WF is member of steering cie of NovoNordisk evoke/evoke + . WF participated in advisory boards of Biogen MA Inc, Roche, and Eli Lilly. WF is member of the steering committee of EVOKE/EVOKE + (NovoNordisk). All funding is paid to her institution. WF is member of the steering committee of PAVE, and Think Brain Health. WF was associate editor of Alzheimer, Research & Therapy in 2020/2021. WF is associate editor at Brain.LB is an employee of Danone Research & Innovation.No conflict of interest were reported by the other co-authors.
